Promoted by The Pharmaceuticals Exports Promotion Council of India (Pharmexcil), the third edition of iPHEX 2015 will be held at Bombay Exhibition Centre from May 13 to 15, 2015. iPHEX 2015 is India’s own pharmaceutical show under the support of Ministry of Commerce & Industry, Department of Commerce, and Government of India.
The exhibition will bring together the drugs, pharmaceutical and healthcare industry, all under one roof. Pharmexcil will organise the exhibition and Ministry of Commerce and Industry, Department of Commerce, Government of India will support it.
Over 20,000 potential buyers including 450 overseas buyers from 89 countries focus areas are being invited to participate in the exhibition. Over 40 drug regulators are attending this mega exhibition event from 15 to 20 countries.
The event will be inaugurated by Hon’ble Minister for Chemicals and Fertilizer Hansraj Gangaram Ahir and Hon’ble Minister for Food, Civil Supplies & Consumer Protection Girish Bapat. Rajeev Kher, Commerce Secretary and Dr G N Singh, Drug Controller General of India will also be attending this mega exhibition.
There is a 6 member top government delegation team coming in from Sri Lanka especially for iPHEX 2015 event. Government of Sri Lanka has nominated the following officers for attending this mega event viz. S Liyanage, chairman, State Pharmaceutical Corporation; KMDR Dassanayake, general manager, State Pharmaceutical Corporation; A Priyadharshana, director, National Drug Quality Assurance Laboratory; M Karunarathne, assistant director, Medical Supplies Division; H M Pushpakumara, assistant director, Medical Supplies Division and J R S Kumara, chief pharmacist, Medical Supplies Division. The event will be co-located with PHARMA Pro&Pack Expo 2015, a show for pharma machinery manufacturers.
Bhavin Mehta, Committee Chief of iPHEX and CoA member, Pharmexcil said “iPHEX 2015 will be a complete value chain show and Pharmexcil is creating a sustainable pharma industry platform with a special focus on exports market development. Besides, this year we have launched a Mobile App called iPHEX Mobile App. This APP is a perfect electronic event guide displaying the list of buyers, exhibitors, their speciality, areas of interest etc at just a click.”
iPhex 2015 itself will bring in the participation of over 325 leading pharmaceutical companies. The exhibitors’ list includes Lupin Laboratories, Mankind Pharma, Ajanta Pharma, Granules India, Charak Pharma etc. There is a technical session that is also one of the important session for the visitors. On the first day of the event, the technical session in the afternoon is on “Regulatory perspective for global opportunities in Nutraceuticals”.
On Day 2, there are two sessions, one in the morning and the second is in the afternoon. The morning session is on “Indian Pharmacopoeia – A Book on Global Standards”. Day 2 afternoon technical session is on “Regulatory Actions By US FDA – Strategies To Handle Business Risks”. The last day, which is Day 3, there is a very interesting technical session in the morning which is on “Interactive Meet With Overseas Regulators”.
Dr P V Appaji, Director General, Pharmexcil said “In this current year, our main focus is to get the recognition of Indian Pharmacopoeia from drug regulators. For this, we are talking to all drug regulators and reassuring them that Pharmexcil would make its best efforts to ensure supply of best quality drugs at affordable prices. Recognition of Indian Pharmacopoeia will help significantly in manufacturing the quality drugs at affordable prices.
Pharmexcil has compared the monographs of Indian Pharmacopoeia, British Pharmacopoeia and United States Pharmacoepia and an examination of these monographs reveals that the stated specifications/standards are similar in nature. If overseas countries recognise Indian Pharmacopoeial standard for registering / testing of quality drugs imported from India, then manufacturers / exporters would be able to manufacture domestic and export purpose drugs in huge quantities with higher batch sizes. The cost of testing would be lower and the advantage of cost saving can be passed on to the importing countries.”
“With increasing R&D spends, Indian pharmaceutical sector has become a cost-effective centre for world class research as also for contract R &D. Indian companies in recent years have produced many cost-effective drugs that are affordable to the masses”, said Ashutosh Gupta, Chairman, Pharmexcil.
“We are making concerted efforts to promote India’s status as the manufacturing hub of the world,” added Gupta. Bhavin Mehta concluded saying “The unique model of exhibition format where each buyer from more than 89 countries meet each and every exhibitor is a model by itself. Due to this model, Pharmexcil has taken a lead to increase the reach of these buyers so that exhibitors can in turn maximize the potential of these buyers and explore new business opportunities”.